Literature DB >> 35241807

The physiology and genetics of bacterial responses to antibiotic combinations.

Roderich Roemhild1, Tobias Bollenbach2,3, Dan I Andersson4.   

Abstract

Several promising strategies based on combining or cycling different antibiotics have been proposed to increase efficacy and counteract resistance evolution, but we still lack a deep understanding of the physiological responses and genetic mechanisms that underlie antibiotic interactions and the clinical applicability of these strategies. In antibiotic-exposed bacteria, the combined effects of physiological stress responses and emerging resistance mutations (occurring at different time scales) generate complex and often unpredictable dynamics. In this Review, we present our current understanding of bacterial cell physiology and genetics of responses to antibiotics. We emphasize recently discovered mechanisms of synergistic and antagonistic drug interactions, hysteresis in temporal interactions between antibiotics that arise from microbial physiology and interactions between antibiotics and resistance mutations that can cause collateral sensitivity or cross-resistance. We discuss possible connections between the different phenomena and indicate relevant research directions. A better and more unified understanding of drug and genetic interactions is likely to advance antibiotic therapy.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35241807     DOI: 10.1038/s41579-022-00700-5

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   78.297


  165 in total

1.  Interdependence of cell growth and gene expression: origins and consequences.

Authors:  Matthew Scott; Carl W Gunderson; Eduard M Mateescu; Zhongge Zhang; Terence Hwa
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

Review 2.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

3.  Opposing effects of target overexpression reveal drug mechanisms.

Authors:  Adam C Palmer; Roy Kishony
Journal:  Nat Commun       Date:  2014-07-01       Impact factor: 14.919

Review 4.  How antibiotics kill bacteria: from targets to networks.

Authors:  Michael A Kohanski; Daniel J Dwyer; James J Collins
Journal:  Nat Rev Microbiol       Date:  2010-05-04       Impact factor: 60.633

Review 5.  Distinguishing between resistance, tolerance and persistence to antibiotic treatment.

Authors:  Asher Brauner; Ofer Fridman; Orit Gefen; Nathalie Q Balaban
Journal:  Nat Rev Microbiol       Date:  2016-04       Impact factor: 60.633

6.  Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days.

Authors:  Leif Tueffers; Camilo Barbosa; Ingrid Bobis; Sabine Schubert; Marc Höppner; Malte Rühlemann; Andre Franke; Philip Rosenstiel; Anette Friedrichs; Annegret Krenz-Weinreich; Helmut Fickenscher; Burkhard Bewig; Stefan Schreiber; Hinrich Schulenburg
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

7.  Clinically relevant mutations in core metabolic genes confer antibiotic resistance.

Authors:  Allison J Lopatkin; Sarah C Bening; Abigail L Manson; Jonathan M Stokes; Michael A Kohanski; Ahmed H Badran; Ashlee M Earl; Nicole J Cheney; Jason H Yang; James J Collins
Journal:  Science       Date:  2021-02-19       Impact factor: 47.728

8.  Selection of resistant bacteria at very low antibiotic concentrations.

Authors:  Erik Gullberg; Sha Cao; Otto G Berg; Carolina Ilbäck; Linus Sandegren; Diarmaid Hughes; Dan I Andersson
Journal:  PLoS Pathog       Date:  2011-07-21       Impact factor: 6.823

9.  Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

Authors:  Guido V Bloemberg; Peter M Keller; David Stucki; David Stuckia; Andrej Trauner; Sonia Borrell; Tsogyal Latshang; Mireia Coscolla; Thomas Rothe; Rico Hömke; Claudia Ritter; Julia Feldmann; Bettina Schulthess; Sebastien Gagneux; Erik C Böttger
Journal:  N Engl J Med       Date:  2015-11-12       Impact factor: 91.245

Review 10.  Proximate and ultimate causes of the bactericidal action of antibiotics.

Authors:  Fernando Baquero; Bruce R Levin
Journal:  Nat Rev Microbiol       Date:  2020-10-06       Impact factor: 60.633

View more
  5 in total

1.  Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue.

Authors:  Véronique Dartois; Thomas Dick
Journal:  J Exp Med       Date:  2022-05-11       Impact factor: 17.579

Review 2.  Anti-tuberculosis treatment strategies and drug development: challenges and priorities.

Authors:  Véronique A Dartois; Eric J Rubin
Journal:  Nat Rev Microbiol       Date:  2022-04-27       Impact factor: 78.297

3.  Mutational Switch-Backs Can Accelerate Evolution of Francisella to a Combination of Ciprofloxacin and Doxycycline.

Authors:  Heer H Mehta; David Ibarra; Christopher J Marx; Craig R Miller; Yousif Shamoo
Journal:  Front Microbiol       Date:  2022-05-09       Impact factor: 6.064

4.  iTDtest: an Easy-to-Handle and Visual Assay To Detect Tolerant and Persister Cells in an Antibiotic Combination Regimen.

Authors:  Laurence Van Melderen
Journal:  mBio       Date:  2022-06-13       Impact factor: 7.786

5.  Impaired Succinate Oxidation Prevents Growth and Influences Drug Susceptibility in Mycobacterium tuberculosis.

Authors:  Cara Adolph; Matthew B McNeil; Gregory M Cook
Journal:  mBio       Date:  2022-07-20       Impact factor: 7.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.